Goldberg Andrew D. (CIK 1827722) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-16). Recent activity: Buy TARS (2,954 shares), Buy TARS (3,350 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-16 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Buy | 2,954 | $0 |
| 2025-06-16 | Tarsus Pharmaceuticals, Inc. (TARS) | Director | Buy | 3,350 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-16